One of the targets, Tmeff1, is a type I transmembrane receptor with signal transduction activity and is known to play a role in cancer progression signaling through induction of erbB4 tyrosine kinase receptor phosphorylation [40] and suppression of Nodal signaling. The gene discussed is NODAL; the disease is cancer.